UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease

Current pharmaceutical design, 2022-01, Vol.28 (40), p.3289-3304

2022

Volltextzugriff (PDF)

The Expression and Molecular Mechanisms of Matrix Metalloproteinase- 9 and Vascular Endothelial Growth Factor in Renal Interstitial Fibrosis in Rats

Current molecular medicine, 2024-12, Vol.24 (12), p.1540-1549

2024

Volltextzugriff (PDF)

Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil

Current pharmaceutical design, 2024-01, Vol.30 (30), p.2400-2409

2024

Volltextzugriff (PDF)

Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease

Current pharmaceutical design, 2024-01, Vol.30 (8), p.589-596

2024

Volltextzugriff (PDF)

Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease

Current pharmaceutical design, 2023-01, Vol.29 (21), p.1659-1670

2023

Volltextzugriff (PDF)

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis

Journal of pharmacy & pharmaceutical sciences, 2019-10, Vol.22, p.365-375

2019

Volltextzugriff (PDF)

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Stem cells international, 2020, Vol.2020 (2020), p.1-11

2020

Volltextzugriff (PDF)

Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases

Frontiers in endocrinology (Lausanne), 2023-12, Vol.14, p.1320603-1320603

2023

Volltextzugriff (PDF)

Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus

Frontiers in immunology, 2023-07, Vol.14, p.1202850-1202850

2023

Volltextzugriff (PDF)

Mesenchymal Stem Cell-conditioned Medium Protecting Renal Tubular Epithelial Cells by Inhibiting Hypoxia-inducible Factor-1α and Nuclear Receptor Coactivator-1

Current stem cell research and therapy, 2024-11, Vol.19 (10), p.1369-1381

2024

Volltextzugriff (PDF)

Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis

Stem cell research & therapy, 2021-06, Vol.12 (1), p.1-333, Article 333

2021

Volltextzugriff (PDF)

Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis

Stem cell research & therapy, 2024-07, Vol.15 (1), p.237-16, Article 237

2024

Volltextzugriff (PDF)

Current and Emerging Drugs in the Treatment of Anemia in Patients with Chronic Kidney Disease

Journal of pharmacy & pharmaceutical sciences, 2020, Vol.23, p.278-288

2020

Volltextzugriff (PDF)

Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors

Cells (Basel, Switzerland), 2022-12, Vol.11 (23), p.3913

2022

Volltextzugriff (PDF)

Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility

BMC medical genetics, 2019-03, Vol.20 (1), p.46-46, Article 46

2019

Volltextzugriff (PDF)

Association of vascular endothelial growth factor (VEGF) protein levels and gene polymorphism with the risk of chronic kidney disease

Libyan journal of medicine, 2023-12, Vol.18 (1), p.2156675-2156675

2023

Volltextzugriff (PDF)

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis

Stem cell research & therapy, 2020-02, Vol.11 (1), p.48-48, Article 48

2020

Volltextzugriff (PDF)

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease

Frontiers in cell and developmental biology, 2022-10, Vol.10

2022

Volltextzugriff (PDF)

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1236404-1236404

2023

Volltextzugriff (PDF)

An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease

Frontiers in endocrinology (Lausanne), 2022-07, Vol.13, p.962635-962635

2022

Volltextzugriff (PDF)

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants

Stem cells international, 2020, Vol.2020 (2020), p.1-12

2020

Volltextzugriff (PDF)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome

Archives of medical science, 2023-01, Vol.19 (3), p.577-585

2023

Volltextzugriff (PDF)

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis

Archives of medical science, 2023, Vol.19 (2), p.411-419

2023

Volltextzugriff (PDF)

An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus

Stem cells international, 2021-08, Vol.2021, p.1-8

2021

Volltextzugriff (PDF)

Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population

BMC medical genetics, 2018-11, Vol.19 (1), p.201-201, Article 201

2018

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Aktive Filter

ThemaEngineering

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(79)
Tagungsberichte
(9)

Sprache

Englisch
(88)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A Systematic Review and Meta-analysis of Efficacy and Safety of Calcimimetic Agents in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease

The Expression and Molecular Mechanisms of Matrix Metalloproteinase- 9 and Vascular Endothelial Growth Factor in Renal Interstitial Fibrosis in Rats

Treatment of Patients with IgA Nephropathy: Evaluation of the Safety and Efficacy of Mycophenolate Mofetil

Relationship between Compound α-Ketoacid and Microinflammation in Patients with Chronic Kidney Disease

Renal Protection and Safety of Sodium-glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease

Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus

Overview of the safety, efficiency, and potential mechanisms of finerenone for diabetic kidney diseases

Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus

Mesenchymal Stem Cell-conditioned Medium Protecting Renal Tubular Epithelial Cells by Inhibiting Hypoxia-inducible Factor-1α and Nuclear Receptor Coactivator-1

Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis

Clinical and preclinical studies of mesenchymal stem cells to alleviate peritoneal fibrosis

Current and Emerging Drugs in the Treatment of Anemia in Patients with Chronic Kidney Disease

Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors

Meta-analysis of associations of vascular endothelial growth factor protein levels and -634G/C polymorphism with systemic lupus erythematosus susceptibility

Association of vascular endothelial growth factor (VEGF) protein levels and gene polymorphism with the risk of chronic kidney disease

Efficacy of mesenchymal stem cells in animal models of lupus nephritis: a meta-analysis

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients

An overview of the efficacy and signaling pathways activated by stem cell-derived extracellular vesicles in diabetic kidney disease

Nephroprotective Effect of Mesenchymal Stem Cell-Based Therapy of Kidney Disease Induced by Toxicants

Rituximab therapy in adults with steroid-dependent nephrotic syndrome

Clinical efficacy and safety of rituximab with membranous nephropathy: a meta-analysis

An Overview of the Safety, Efficiency, and Signal Pathways of Stem Cell Therapy for Systemic Lupus Erythematosus

Relationship between transforming growth factor-β1 and type 2 diabetic nephropathy risk in Chinese population

Aktive Filter

Suchergebnisse filtern